142 related articles for article (PubMed ID: 18166633)
1. Metalloproteinase expression in carotid plaque and its correlation with plasma levels before and after carotid endarterectomy.
Taurino M; Raffa S; Mastroddi M; Visco V; Rizzo L; Torrisi MR; Faraglia V
Vasc Endovascular Surg; 2007 Dec-2008 Jan; 41(6):516-21. PubMed ID: 18166633
[TBL] [Abstract][Full Text] [Related]
2. MMP and TIMP alterations in asymptomatic and symptomatic severe recurrent carotid artery stenosis.
Sapienza P; Borrelli V; di Marzo L; Cavallaro A
Eur J Vasc Endovasc Surg; 2009 May; 37(5):525-30. PubMed ID: 19297218
[TBL] [Abstract][Full Text] [Related]
3. Plasma MMP-2-TIMP-2 complex levels measured during follow-up predict a risk of relapse in patients with malignant lymphoma.
Pennanen H; Kuittinen O; Turpeenniemi-Hujanen T
Eur J Haematol; 2008 Jan; 80(1):46-54. PubMed ID: 18028436
[TBL] [Abstract][Full Text] [Related]
4. Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression.
Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Piagnerelli R; Cavallaro A
Eur J Vasc Endovasc Surg; 2004 Jul; 28(1):89-97. PubMed ID: 15177237
[TBL] [Abstract][Full Text] [Related]
5. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis.
Alvarez B; Ruiz C; Chacón P; Alvarez-Sabin J; Matas M
J Vasc Surg; 2004 Sep; 40(3):469-75. PubMed ID: 15337875
[TBL] [Abstract][Full Text] [Related]
6. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues.
Choudhary S; Higgins CL; Chen IY; Reardon M; Lawrie G; Vick GW; Karmonik C; Via DP; Morrisett JD
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2351-8. PubMed ID: 16888239
[TBL] [Abstract][Full Text] [Related]
7. Plasma MMP-9 - a marker of carotid plaque instability.
Loftus IM; Naylor AR; Bell PR; Thompson MM
Eur J Vasc Endovasc Surg; 2001 Jan; 21(1):17-21. PubMed ID: 11170872
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinase levels are decreased in symptomatic carotid plaques.
Hower CD; Dassow MS; Kajdacsy-Balla A; Seabrook GR; Jean-Claude J; Towne JB; Cambria RA
J Surg Res; 2000 Feb; 88(2):155-9. PubMed ID: 10644482
[TBL] [Abstract][Full Text] [Related]
9. Role of platelet-derived growth factor and transforming growth factor beta1 the in the regulation of metalloproteinase expressions.
Borrelli V; di Marzo L; Sapienza P; Colasanti M; Moroni E; Cavallaro A
Surgery; 2006 Sep; 140(3):454-63. PubMed ID: 16934609
[TBL] [Abstract][Full Text] [Related]
10. Markers of instability in high-risk carotid plaques are reduced by statins.
Kunte H; Amberger N; Busch MA; Rückert RI; Meiners S; Harms L
J Vasc Surg; 2008 Mar; 47(3):513-22. PubMed ID: 18295103
[TBL] [Abstract][Full Text] [Related]
11. Metalloproteinases and their inhibitors are markers of plaque instability.
Sapienza P; di Marzo L; Borrelli V; Sterpetti AV; Mingoli A; Cresti S; Cavallaro A
Surgery; 2005 Mar; 137(3):355-63. PubMed ID: 15746792
[TBL] [Abstract][Full Text] [Related]
12. Deferred urgency carotid artery stenting in symptomatic patients: clinical lessons and biomarker patterns from a prospective registry.
Setacci C; de Donato G; Chisci E; Setacci F; Stella A; Faggioli G; Reimers B; Cernetti C; Lopera Quijada MJ; Cappi B; Sangiorgi G;
Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):644-51. PubMed ID: 18367416
[TBL] [Abstract][Full Text] [Related]
13. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis.
van Oostrom O; Velema E; Schoneveld AH; de Vries JP; de Bruin P; Seldenrijk CA; de Kleijn DP; Busser E; Moll FL; Verheijen JH; Virmani R; Pasterkamp G
Cardiovasc Pathol; 2005; 14(3):126-34. PubMed ID: 15914297
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome.
Gonçalves FM; Jacob-Ferreira AL; Gomes VA; Casella-Filho A; Chagas AC; Marcaccini AM; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2009 May; 403(1-2):173-7. PubMed ID: 19254704
[TBL] [Abstract][Full Text] [Related]
15. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
[TBL] [Abstract][Full Text] [Related]
16. Concentration of matrix metalloproteinase-9 in the jugular bulb during carotid endarterectomy correlates with severity of intraoperative cerebral ischemia.
Ishigaki D; Ogasawara K; Suga Y; Saito H; Chida K; Kobayashi M; Yoshida K; Otawara Y; Ogawa A
Cerebrovasc Dis; 2008; 25(6):587-92. PubMed ID: 18503252
[TBL] [Abstract][Full Text] [Related]
17. Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents.
Belo VA; Souza-Costa DC; Lana CM; Caputo FL; Marcaccini AM; Gerlach RF; Bastos MG; Tanus-Santos JE
Clin Biochem; 2009 Jul; 42(10-11):984-90. PubMed ID: 19358835
[TBL] [Abstract][Full Text] [Related]
18. [Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma].
Klisho EV; Savenkova OV; Kondakova IV; Perel'muter VM; Choĭnzonov EL; Shishkin DA
Vopr Onkol; 2007; 53(1):26-31. PubMed ID: 17649730
[TBL] [Abstract][Full Text] [Related]
19. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
[TBL] [Abstract][Full Text] [Related]
20. [Serum levels of matrix metaloproteinase 2 (MMP-2), matrix metaloproteinase 9 (MMP-9) and tissue inhibitor of metaloproteinase 2 (TIMP-2) in children and adolescents with growth hormone deficiency].
Szczepańska-Kostro J; Kowalewski M; Urban M; Gardziejczyk M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):257-60. PubMed ID: 17239302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
